These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7972773)

  • 1. Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging.
    Reimer P; Weissleder R; Shen T; Knoefel WT; Brady TJ
    Radiology; 1994 Nov; 193(2):527-31. PubMed ID: 7972773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral iron oxide distribution: in vivo mapping with MR imaging.
    Zimmer C; Weissleder R; O'Connor D; LaPointe L; Brady TJ; Enochs WS
    Radiology; 1995 Aug; 196(2):521-7. PubMed ID: 7617871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells.
    Shen TT; Bogdanov A; Bogdanova A; Poss K; Brady TJ; Weissleder R
    Bioconjug Chem; 1996; 7(3):311-6. PubMed ID: 8816953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human transferrin receptor gene as a marker gene for MR imaging.
    Moore A; Josephson L; Bhorade RM; Basilion JP; Weissleder R
    Radiology; 2001 Oct; 221(1):244-50. PubMed ID: 11568347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
    Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
    Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
    Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin-1 receptor protein up-regulation during pancreatic regeneration after acute haemorrhagic pancreatitis in rats.
    Yoshikawa H; Nakamura H; Tashiro M; Yamaguchi T; Taguchi M; Fukumitsu K; Otsuki M
    Eur J Clin Invest; 2004 Jul; 34(7):498-507. PubMed ID: 15255787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of in vivo MR imaging of slow axonal transport.
    van Everdingen KJ; Enochs WS; Bhide PG; Nossiff N; Papisov M; Bogdanov A; Brady TJ; Weissleder R
    Radiology; 1994 Nov; 193(2):485-91. PubMed ID: 7526413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
    Chowdhury P; Rayford PL
    Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
    Weissleder R; Elizondo G; Wittenberg J; Lee AS; Josephson L; Brady TJ
    Radiology; 1990 May; 175(2):494-8. PubMed ID: 2326475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultra-small superparamagnetic iron oxide particles: the signal behavior and relaxation times of the bone marrow after repeated i.v. application in the pig model at 1.5 tesla].
    Cihal S; Maas R; Delling G; Klich S; Nielsen P; Lodemann KP; Bücheler E
    Rofo; 1999 Aug; 171(2):149-54. PubMed ID: 10506890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny and species differences in the pancreatic expression and localization of the CCK(A) receptors.
    Bourassa J; Lainé J; Kruse ML; Gagnon MC; Calvo E; Morisset J
    Biochem Biophys Res Commun; 1999 Jul; 260(3):820-8. PubMed ID: 10403848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR lymphography: study of a high-efficiency lymphotrophic agent.
    Weissleder R; Heautot JF; Schaffer BK; Nossiff N; Papisov MI; Bogdanov A; Brady TJ
    Radiology; 1994 Apr; 191(1):225-30. PubMed ID: 8134576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
    Frank JA; Miller BR; Arbab AS; Zywicke HA; Jordan EK; Lewis BK; Bryant LH; Bulte JW
    Radiology; 2003 Aug; 228(2):480-7. PubMed ID: 12819345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.